Involuntary movement disorders.
Excluding surgical procedures, this article focuses on clinical pharmacotherapeutic approaches to treatment of parkinsonism and tremor, chorea, dystonia, tic, and tardive dyskinesia.
D001921:Brain / Q000378:metabolism; D002819:Chorea / Q000188:drug therapy; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D004422:Dystonia Musculorum Deformans / Q000188:drug therapy; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D007980:Levodopa / Q000627:therapeutic use; D008538:Meige Syndrome / Q000188:drug therapy; D009069:Movement Disorders / Q000188:drug therapy* / Q000378:metabolism; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy
D010276:Parasympatholytics; D007980:Levodopa